{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:23:36Z","timestamp":1726759416218},"reference-count":33,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2011]]},"DOI":"10.3960\/jslrt.51.29","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T05:57:56Z","timestamp":1306821476000},"page":"29-35","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum"],"prefix":"10.3960","volume":"51","author":[{"given":"Tomoaki","family":"Akagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnichi","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Noji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shichishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jugoh","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 89:3909-3918, 1997","DOI":"10.1182\/blood.V89.11.3909"},{"key":"2","unstructured":"2 Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Bri&egrave;re J, <I>et al<\/I>. : Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Group d'Etudes des Lymphomes de I'Adulte (GELA). Blood 92:76-82, 1998"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Rodriguez-Abreu D, Filho VB, Zucca E: Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Hematol Oncol 26:8-20, 2008","DOI":"10.1002\/hon.836"},{"key":"4","unstructured":"4 Nakamura S, Suchi T, Koshikawa T, Suzuki H, Oyama A, <I>et al<\/I>. : Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 72:1762-1772, 1993"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008200307625"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Melnyk A, Rodriguez A, Pugh WC, Cabannillas F: Evaluation of the Revised European-American Lymphoma Classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 89:4514-4520, 1997","DOI":"10.1182\/blood.V89.12.4514"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Intragumtornchai T, Rotnakkarin P, Sutcharitchan P, Wannagrairoj P: Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma. Clin Lymphoma 4:52-55, 2003","DOI":"10.3816\/CLM.2003.n.014"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008418727472"},{"key":"10","unstructured":"10 Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, <I>et al<\/I>. : Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma 44:241-249, 2003"},{"key":"11","unstructured":"11 Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, <I>et al<\/I>. : Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity. Blood 86:1954-1960, 1995"},{"key":"12","unstructured":"12 Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, <I>et al<\/I>. : ALK<SUP>+<\/SUP> lymphoma: clinico-pathological findings and outcome. Blood 93:2697-2706, 1999"},{"key":"13","unstructured":"13 Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, <I>et al<\/I>. : Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 93:3913-3921, 1999"},{"key":"14","unstructured":"14 Jaffe ES, Haris NL, Stein H, Vardiman JW: World Health Organization Classification of Tumors, Volume 3: Pathology and Genetics of tumors of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer ; 2001"},{"key":"15","unstructured":"15 Kojima H, Hasegawa Y, Suzukawa K, Mukai HY, Kaneko S, <I>et al<\/I>. : Clinicopathological features and prognostic factors of Japanese patients with &ldquo;peripheral T-cell lymphoma, unspecified&rdquo; diagnosed according to the WHO classification. Leuk Res 28:1287-1292, 2004"},{"key":"16","unstructured":"16 Tomita N, Motomura S, Hyo R, Takasaki H, Takemura S, <I>et al<\/I>. : Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Cancer 109:1146-1151, 2007"},{"key":"17","unstructured":"17 Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, <I>et al<\/I>. : Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. Cancer 101:1601-1608, 2004"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.131"},{"key":"20","unstructured":"20 Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, <I>et al<\/I>. : Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23:5027-5033, 2005"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.503"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Lippman SM, Miller TP, Spier CM, Slymen DJ, Grogan TM: The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 72:436-441, 1988","DOI":"10.1182\/blood.V72.2.436.bloodjournal722436"},{"key":"23","unstructured":"23 Cheng AL, Chen YC, Wang CH, Su IJ, Hsieh HC, <I>et al<\/I>. : Direct comparison of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades. Should peripheral T-cell lymphoma be considered separately? J Clin Oncol 7:725-731, 1989"},{"key":"24","unstructured":"24 Kwak LW, Wilson M, Weiss LM, Doggett R, Dorfman RF, <I>et al<\/I>. : Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphoma: the Stanford experience. J Clin Oncol 9:1426-1431, 1991"},{"key":"25","unstructured":"25 Vose J, Peterson C, Bierman PJ, Weisenburger DD, Linder J, <I>et al<\/I>. : Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 76:424-431, 1990"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702867"},{"key":"27","unstructured":"27 Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, <I>et al<\/I>. : Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 19:3766-3770, 2001"},{"key":"28","unstructured":"28 Rodriguez J, Caballero MD, Gutierrez A, Mar&#237;n J, Lahuerta JJ, <I>et al<\/I>. : High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 14:1768-1775, 2003"},{"key":"29","unstructured":"29 Kewalramini T, Zelenetz AD, Teruya-Feldstein J, Hamlin P, Yahalom J, <I>et al<\/I>. : Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma. Br J Haematol 134:202-207, 2006"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.165"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR: Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 49:2099-2107, 2008","DOI":"10.1080\/10428190802455867"},{"key":"32","unstructured":"32 Enblad G, Hagberg H, Erlanson M, Lundin J, MacDonald AP, <I>et al<\/I>. : A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 103:2920-2924, 2004"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:01Z","timestamp":1621539961000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jslrt\/51\/1\/51_1_29\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.51.29","relation":{},"ISSN":["1880-9952","1346-4280"],"issn-type":[{"value":"1880-9952","type":"electronic"},{"value":"1346-4280","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}